These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 35455363)

  • 21. The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options.
    Choudhary S; Sharma K; Silakari O
    Microb Pathog; 2021 Jan; 150():104673. PubMed ID: 33278517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
    Sasidharakurup H; Kumar G; Nair B; Diwakar S
    OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
    Wang J; Jiang M; Chen X; Montaner LJ
    J Leukoc Biol; 2020 Jul; 108(1):17-41. PubMed ID: 32534467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections.
    Liu T; Feng M; Wen Z; He Y; Lin W; Zhang M
    J Inflamm Res; 2021; 14():5475-5487. PubMed ID: 34720596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed storm in SARS-CoV-2 infection: A narrative review and new term in the Covid-19 era.
    Alomair BM; Al-Kuraishy HM; Al-Gareeb AI; Al-Buhadily AK; Alexiou A; Papadakis M; Alshammari MA; Saad HM; Batiha GE
    Immun Inflamm Dis; 2023 Apr; 11(4):e838. PubMed ID: 37102645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of the immune response in coronavirus disease 2019.
    Mohamed Khosroshahi L; Rezaei N
    Cell Biol Int; 2021 Apr; 45(4):702-707. PubMed ID: 33289192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options.
    Nazerian Y; Ghasemi M; Yassaghi Y; Nazerian A; Hashemi SM
    Int Immunopharmacol; 2022 Dec; 113(Pt B):109428. PubMed ID: 36379152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review.
    Tirelli C; De Amici M; Albrici C; Mira S; Nalesso G; Re B; Corsico AG; Mondoni M; Centanni S
    Biology (Basel); 2023 Jan; 12(2):. PubMed ID: 36829456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.
    Anka AU; Tahir MI; Abubakar SD; Alsabbagh M; Zian Z; Hamedifar H; Sabzevari A; Azizi G
    Scand J Immunol; 2021 Apr; 93(4):e12998. PubMed ID: 33190302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
    Chong ZZ; Souayah N
    Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting cytokine storm as the potential anti-viral therapy: Implications in regulating SARS-CoV-2 pathogenicity.
    Maity S; Santra A; Hebbani AV; Pulakuntla S; Chatterjee A; Badri KR; Damodara Reddy V
    Gene; 2023 Sep; 881():147612. PubMed ID: 37423400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics.
    Chavda VP; Raval N; Sheta S; Vora LK; Elrashdy F; Redwan EM; Uversky VN; Ertas YN
    Front Immunol; 2023; 14():1064459. PubMed ID: 37153613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
    Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
    Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications.
    Rowaiye AB; Okpalefe OA; Onuh Adejoke O; Ogidigo JO; Hannah Oladipo O; Ogu AC; Oli AN; Olofinase S; Onyekwere O; Rabiu Abubakar A; Jahan D; Islam S; Dutta S; Haque M
    J Inflamm Res; 2021; 14():1487-1510. PubMed ID: 33889008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19: imbalanced cell-mediated immune response drives to immunopathology.
    Wang J; Li Q; Qiu Y; Lu H
    Emerg Microbes Infect; 2022 Dec; 11(1):2393-2404. PubMed ID: 36069182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19.
    Wang M; Chang W; Zhang L; Zhang Y
    Int J Biol Sci; 2022; 18(15):5827-5848. PubMed ID: 36263178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.